30 Participants Needed

Remote Ischemic Conditioning for Healthy Adults

SM
SS
Overseen ByShailesh S Gardas, PT
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

Remote ischemic conditioning (RIC) is a clinically feasible method that protects distant organs from severe injury through brief, sub lethal periods of ischemia followed by re-perfusion. Recent studies suggest that RIC, combined with training, improves muscle strength and balance in healthy adults and post-stroke survivors. While the underlying mechanisms are not fully understood, RIC's neuroprotective effects - such as promoting angiogenesis, neurogenesis, and modulating glutamate and GABA synthesis - overlap with neuroplasticity processes. Evidence indicates that neuroplasticity from exercise training occurs not only in the cerebral cortex but also within the spinal cord, yet the role of spinal reflex mechanisms underlying the benefits of RIC remains under explored. Therefore, this study aims to investigate effects of RIC on spinal reflex modulation in healthy adults, both independently and combined with balance training.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

Is remote ischemic conditioning safe for humans?

Remote ischemic conditioning has been shown to be safe and feasible in patients with acute ischemic stroke and those undergoing certain treatments. It is gaining interest for its potential protective effects in various clinical settings, and studies have not reported significant safety concerns.12345

How is the treatment Remote Ischemic Conditioning unique for silent ischemia?

Remote Ischemic Conditioning is unique because it involves applying brief, controlled periods of reduced blood flow to a limb, which can help protect the heart by triggering the body's natural protective mechanisms, unlike traditional treatments that focus on medication or surgical procedures.678910

What data supports the effectiveness of the treatment Remote Ischemic Conditioning for Healthy Adults?

Remote ischemic conditioning has shown potential benefits in other conditions, such as reducing injury in heart and stroke patients by improving blood flow and protecting tissues. While these studies focus on different health issues, they suggest that remote ischemic conditioning might have positive effects on the body.12111213

Who Is on the Research Team?

SM

Swati M Surkar, PT, PhD

Principal Investigator

East Carolina University

Are You a Good Fit for This Trial?

This trial is for healthy young adults who may have a condition called Ocular Ischemia Syndrome. Participants should be interested in exploring how certain non-invasive treatments can potentially improve muscle strength and balance.

Inclusion Criteria

I am a healthy adult between 18 and 40 years old.

Exclusion Criteria

Individuals who are pregnant
Individuals with balance disorders such as vestibular disorders
I have difficulty seeing.
See 3 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Baseline Assessment

Participants undergo H-reflex testing and balance assessments

1 day
1 visit (in-person)

Treatment

Participants undergo RIC or sham conditioning combined with balance training over multiple sessions

5 days
5 visits (in-person)

Follow-up

Participants are monitored for changes in H-reflex amplitude and balance performance

1 week
1 visit (in-person)

What Are the Treatments Tested in This Trial?

Interventions

  • Balance training
  • Remote Ischemic Conditioning
  • Sham Conditioning
Trial Overview The study tests Remote Ischemic Conditioning (RIC), which involves brief periods of controlled blood flow restriction, followed by restoration. It's being studied alone and with balance training to see if it helps spinal reflexes and improves balance.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Remote Ischemic Conditioning (RIC)Experimental Treatment2 Interventions
Group II: Sham conditioningPlacebo Group2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

East Carolina University

Lead Sponsor

Trials
111
Recruited
42,400+

Published Research Related to This Trial

A systematic review of 13 randomized clinical trials involving 7183 patients found that remote ischemic conditioning (RIC) did not significantly reduce mortality rates in acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI) over a median follow-up of 1 year.
RIC also showed no significant effect on the incidence of myocardial infarction (MI) or congestive heart failure (CHF), indicating that this intervention may not provide the expected clinical benefits in these patient populations.
Remote Ischemic Conditioning in Patients with Acute Coronary Syndromes: A Systematic Review with Meta-Analysis and Trial Sequential Analysis.Sandven, I., Eritsland, J., Abdelnoor, M.[2022]
Remote ischemic conditioning (RIC) was found to be safe and feasible for 20 patients with acute ischemic stroke undergoing endovascular treatment, with no serious RIC-related adverse events reported during the study.
At the 3-month follow-up, 55% of patients achieved functional independence, suggesting potential benefits of RIC, although further research is needed to confirm its efficacy.
Remote ischemic conditioning for acute stroke patients treated with thrombectomy.Zhao, W., Che, R., Li, S., et al.[2022]

Citations

Remote Ischemic Conditioning in Patients with Acute Coronary Syndromes: A Systematic Review with Meta-Analysis and Trial Sequential Analysis. [2022]
Remote ischemic conditioning to protect against ischemia-reperfusion injury: a systematic review and meta-analysis. [2022]
Remote Ischemic Conditioning May Improve Disability and Cognition After Acute Ischemic Stroke: A Pilot Randomized Clinical Trial. [2021]
Remote Ischemic Conditioning in Acute Ischemic Stroke - A Clinical Trial Design. [2020]
Effect of remote ischemic conditioning on myocardial perfusion in patients with suspected ischemic coronary artery disease. [2019]
Remote ischemic conditioning for acute stroke patients treated with thrombectomy. [2022]
Remote ischemic conditioning: evolution of the concept, mechanisms, and clinical application. [2022]
Translational challenges of remote ischemic conditioning in ischemic stroke - a systematic review. [2022]
Silent ischemia: clinical relevance. [2022]
10.United Statespubmed.ncbi.nlm.nih.gov
Can we really justify the treatment of silent ischemia in 1992? No! [2020]
Current status of silent myocardial ischemia. [2013]
12.Russia (Federation)pubmed.ncbi.nlm.nih.gov
[Characteristics of coronary artery lesions in patients with painless myocardial ischemia]. [2017]
13.United Statespubmed.ncbi.nlm.nih.gov
Silent ischemia in rehabilitation patients: limited clinical utility of electrocardiographic monitoring. [2007]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security